Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive information.
This move was revealed following a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since explained that the US was demanding access to genetic material for research and commercial gain but was not willing to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the US government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government deals to boost openness and accountability.
Based on reports, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no assurance that the final treatments would be available to our citizens should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This framework is designed to guarantee that when a nation contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome ongoing dialogue with our US partners on how subsequent collaboration might be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Response
Medical experts expressed it understood the government's concerns, but urged that talks should continue since much of the nation's Aids initiatives depended on international support.
"If technical issues exist, including those relating to data governance or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group said.
The halted deal highlights the ongoing debate between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.